SPRR3 | Small proline-rich protein 3 | Cancer-related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44467/144094_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CNFN | Cornifelin | | | ![](/images/53997/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49073/110082_B_8_4_rna_selected_60x60.jpg) | Group enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | ![](/images/49491/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/60121/145140_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SPINK5 | Serine peptidase inhibitor, Kazal type 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/9067/ihc_cell_selected_60x60.jpg) | ![](/images/9067/24812_B_9_4_rna_selected_60x60.jpg) | Group enriched |
SPRR1A | Small proline-rich protein 1A | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11237/120268_B_9_2_rna_selected_60x60.jpg) | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41874/86782_B_4_2_rna_selected_60x60.jpg) | Group enriched |
PI3 | Peptidase inhibitor 3, skin-derived | Plasma proteins Predicted secreted proteins
| | ![](/images/17737/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17737/144088_B_5_1_rna_selected_60x60.jpg) | Group enriched |
LYPD3 | LY6/PLAUR domain containing 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41797/88183_B_8_2_rna_selected_60x60.jpg) | Group enriched |
BNIPL | BCL2/adenovirus E1B 19kD interacting protein like | Predicted membrane proteins
| | ![](/images/19946/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19946/45530_B_9_4_rna_selected_60x60.jpg) | Group enriched |
CRNN | Cornulin | | | ![](/images/24343/if_selected_60x60.jpg) | ![](/images/26182/ihc_cell_selected_60x60.jpg) | ![](/images/24343/54917_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
CD207 | CD207 molecule, langerin | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/11216/if_selected_60x60.jpg) | ![](/images/11216/ihc_cell_selected_60x60.jpg) | ![](/images/11216/27980_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
SERPINB13 | Serpin peptidase inhibitor, clade B (ovalbumin), member 13 | Cancer-related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57129/131356_A_5_7_rna_selected_60x60.jpg) | Tissue enriched |
TRIM29 | Tripartite motif containing 29 | | | | ![](/images_static/rna_center.gif) | ![](/images/20053/46555_B_7_7_rna_selected_60x60.jpg) | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50920/117820_B_8_4_rna_selected_60x60.jpg) | Group enriched |
PLEKHN1 | Pleckstrin homology domain containing, family N member 1 | | | ![](/images/31742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31742/73584_B_9_1_rna_selected_60x60.jpg) | Group enriched |
TMPRSS11E | Transmembrane protease, serine 11E | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/51062/ihc_cell_selected_60x60.jpg) | ![](/images/51062/128329_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/37328/71214_B_7_8_rna_selected_60x60.jpg) | Group enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/133/2841_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
KRT4 | Keratin 4 | Cancer-related genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2154/6019_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
SERPINB3 | Serpin peptidase inhibitor, clade B (ovalbumin), member 3 | Cancer-related genes Plasma proteins
| | ![](/images/36006/if_selected_60x60.jpg) | ![](/images/18772/ihc_cell_selected_60x60.jpg) | ![](/images/18772/42106_B_6_5_rna_selected_60x60.jpg) | Tissue enriched |
SERPINB4 | Serpin peptidase inhibitor, clade B (ovalbumin), member 4 | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55992/132174_B_5_7_rna_selected_60x60.jpg) | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted membrane proteins
| | ![](/images/55214/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55214/129352_B_8_3_rna_selected_60x60.jpg) | Group enriched |
UPK3B | Uroplakin 3B | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10506/26468_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/19287/43914_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/47320/103192_B_8_6_rna_selected_60x60.jpg) | Group enriched |
EVPL | Envoplakin | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53969/140798_B_7_2_rna_selected_60x60.jpg) | Group enriched |
KRT15 | Keratin 15 | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24554/53982_B_6_2_rna_selected_60x60.jpg) | Group enriched |
KRT6B | Keratin 6B | Disease related genes Plasma proteins
| | ![](/images/130/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45697/118501_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
SCGB2A2 | Secretoglobin, family 2A, member 2 | Cancer-related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26270/54439_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/44165/102041_B_8_8_rna_selected_60x60.jpg) | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes
| | ![](/images/21573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21573/50402_B_8_6_rna_selected_60x60.jpg) | Group enriched |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/38848/ihc_cell_selected_60x60.jpg) | ![](/images/38848/81982_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39695/89977_B_6_8_rna_selected_60x60.jpg) | Tissue enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17045/39405_B_8_2_rna_selected_60x60.jpg) | Group enriched |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46864/148887_B_4_3_rna_selected_60x60.jpg) | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/37324/70856_B_8_1_rna_selected_60x60.jpg) | Group enriched |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33680/65962_A_6_1_rna_selected_60x60.jpg) | Group enriched |
FGFBP1 | Fibroblast growth factor binding protein 1 | Cancer-related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4332/13834_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GBP6 | Guanylate binding protein family, member 6 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27744/147433_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21516/109609_B_7_2_rna_selected_60x60.jpg) | Group enriched |
KRT5 | Keratin 5 | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/59479/133812_B_8_1_rna_selected_60x60.jpg) | Group enriched |
LY6D | Lymphocyte antigen 6 complex, locus D | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24755/58231_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PADI1 | Peptidyl arginine deiminase, type I | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62294/148131_B_4_4_rna_selected_60x60.jpg) | Tissue enriched |
PITX1 | Paired-like homeodomain 1 | Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/8743/23430_B_7_4_rna_selected_60x60.jpg) | Group enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48489/114605_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15480/35524_A_4_6_rna_selected_60x60.jpg) | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | ![](/images/6268/ihc_cell_selected_60x60.jpg) | ![](/images/6268/17244_A_2_3_rna_selected_60x60.jpg) | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16662/ihc_cell_selected_60x60.jpg) | ![](/images/16662/37497_B_7_1_rna_selected_60x60.jpg) | Group enriched |
TGM1 | Transglutaminase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/58875/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40171/152708_B_5_3_rna_selected_60x60.jpg) | Tissue enriched |